Skip to main content
PRFX
NASDAQ Life Sciences

PRF Technologies Files F-1 for Resale of Shares Under New $15M Highly Dilutive Equity Line

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.612
Mkt Cap
$1.39M
52W Low
$1.28
52W High
$17.95
52W Position info
26% above low
Off High info
91% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PRFX sits 26% above its 52-week low of $1.28 on light trading volume (0.2× avg).

Summary

PRF Technologies has registered shares for resale under a new $15.0 million dilutive equity line, which could result in over 240% dilution to existing shareholders and signals an ongoing reliance on unfavorable financing terms.


Key Events · Financing and Capital Events · PRFX

  • New $15.0 Million Equity Line Agreement

    The company entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. on June 18, 2026, allowing it to sell up to $15.0 million in ordinary shares over 36 months.

  • Significant Share Registration for Resale

    This F-1 registers 7,500,000 ordinary shares for resale by YA, comprising 20,276 commitment shares and 7,479,724 advance shares that may be issued for cash.

  • Extreme Potential Dilution

    If all 7,479,724 advance shares are issued, it would represent approximately 246% dilution to the 3,041,830 ordinary shares currently outstanding.

  • Discounted Share Pricing

    Shares will be purchased by YA at 97% of the lowest of the three daily volume-weighted average prices (VWAPs) during a pricing period, indicating a discount to market.


Analysis · PRFX · Life Sciences

PRF Technologies has filed an F-1 registration statement for the resale of up to 7,500,000 ordinary shares by YA II PN, LTD. This relates to a new Standby Equity Purchase Agreement (SEPA) dated June 18, 2026, under which the company may sell up to $15.0 million in shares to YA. This agreement replaces a recently terminated $10.0 million SEPA, indicating a continuous and substantial need for capital. The potential issuance of 7,479,724 new shares for cash represents an approximate 246% dilution to current shareholders, significantly exceeding the company's current market capitalization. The shares will be sold at a discount to market prices, highlighting the unfavorable terms necessary to secure this financing and the severe dilutive impact on existing equity.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRFX was trading at $1.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $1.28 to $17.95. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 13, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7834
Real-time Price: $0.660 info
Change: -$0.1234 (-16%) info
Market Cap: $2.011M info
PRFX
Nov 12, 2026, 4:31 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7354
Real-time Price: $0.660 info
Change: -$0.0754 (-10%) info
Market Cap: $2.011M info
PRFX
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.786
Real-time Price: $0.660 info
Change: -$0.126 (-16%) info
Market Cap: $2.011M info
PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.660 info
Change: -$0.0988 (-13%) info
Market Cap: $2.011M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.660 info
Change: -$0.1105 (-14%) info
Market Cap: $2.011M info